Chronic Posterior Laryngitis with suspected Laryngopharyngeal Reflux

Study identifier:SH-NEE-0002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicenter, double -blind, Placebo-controlled Study to evaluate the effects of Esomeprazole 40mg bid on the signs and symptoms of Chronic Posterior Laryngitis with suspected Laryngopharyngeal Reflux

Medical condition

Chronic Posterior Laryngitis (CPL)

Phase

Phase 4

Healthy volunteers

No

Study drug

Esomeprazole, Placebo

Sex

All

Actual Enrollment

120

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Feb 2002
Primary Completion Date: 01 Mar 2003
Study Completion Date: 01 Mar 2003

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2011 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria